When a physician prescribes or treats a patient with your specialty drug, the stakes are high for everyone. Patient access is evolving to improve the patient and physician journey with specialty therapies
Heather Morel, PhD, SVP/GM, Access & Adherence, RxCrossroads by McKesson
Advertisement
Articles by Heather Morel, PhD, SVP/GM, Access & Adherence, RxCrossroads by McKesson
Advertisement
Latest Updated Articles
- Evolving Patient Access Programs for Specialty Therapies
Published: April 1st 2020 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Trump Threatens 10% Tariff Hike on Canadian Imports After Controversial Reagan Ad Airs During World Series
2
Pharma Pulse: Cholesterol Imbalance Tied to Depression Risk, Lilly Acquires Aderum Biotechnologies, and Cambrex Expands API Manufacturing
3
